A liver stiffness measurement-based, noninvasive prediction model for high-risk esophageal varices in B-viral liver cirrhosis

American Journal of Gastroenterology

Volumn 105, Issue 6, 2010, Pages 1382-1390

  Kim, Beom Kyung ^a   Han, Kwang Hyub ^a,b,c   Park, Jun Yong ^a,b   Ahn, Sang Hoon ^a,b   Kim, Ja Kyung ^a,b   Paik, Yong Han ^a,b,c   Lee, Kwan Sik ^a,b   Chon, Chae Yoon ^a,b   Kim, Do Young ^a,b  

^a Yonsei University College of Medicine   (South Korea)

^b Liver Cirrhosis Clinical Research Center   (South Korea)

^c Yonsei University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; HEMOGLOBIN;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; DIAGNOSTIC ACCURACY; ECHOGRAPHY; ENDOSCOPY; ESOPHAGUS VARICES; FEMALE; HEMOGLOBIN BLOOD LEVEL; HEPATITIS B VIRUS; HUMAN; LASER MICROSCOPY; LEUKOCYTE COUNT; LIVER CIRRHOSIS; LIVER STIFFNESS MEASUREMENT; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; MEASUREMENT; NON INVASIVE PROCEDURE; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTHROMBIN TIME; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY; SEX DIFFERENCE; SPLEEN; THROMBOCYTE COUNT;

ADULT; ESOPHAGEAL AND GASTRIC VARICES; ESOPHAGOSCOPY; FEMALE; HEPATITIS B; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS;

EID: 77953232338     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2009.750     Document Type: Article

References (33)

1. de Franchis R. Non-invasive (and minimally invasive) diagnosis of oesophageal varices. J Hepatol 2008; 49: 520-527
2. de Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2005; 43: 167-176
3. Bosch J, Berzigotti A, Garcia-Pagan JC et al. The management of portal hypertension: rational basis, available treatments and future options. J Hepatol 2008; 48 (Suppl 1): S68-92.
4. Merli M, Nicolini G, Angeloni S et al. Incidence and natural history of small esophageal varices in cirrhotic patients. J Hepatol 2003; 38: 266-272
5. Garcia-Tsao G, Sanyal AJ, Grace ND et al. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology 2007; 46: 922-938 (Pubitemid 47436138)
6. Giannini E, Botta F, Borro P et al. Platelet count/spleen diameter ratio: proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosis. Gut 2003; 52: 1200-1205
7. Kazemi F, Kettaneh A, N'Kontchou G et al. Liver stiff ness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices. J Hepatol 2006; 45: 230-235
8. Gentile I, Viola C, Graf M et al. A simple noninvasive score predicts gastroesophageal varices in patients with chronic viral hepatitis. J Clin Gastroenterol 2008; e-pub ahead of print.
9. Vizzutti F, Arena U, Romanelli RG et al. Liver stiff ness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology 2007; 45: 1290-1297
10. Berzigotti A, Gilabert R, Abraldes JG et al. Noninvasive prediction of clinically signifi cant portal hypertension and esophageal varices in patients with compensated liver cirrhosis. Am J Gastroenterol 2008; 103: 1159-1167
11. Giannini EG, Zaman A, Kreil A et al. Platelet count/spleen diameter ratio for the noninvasive diagnosis of esophageal varices: results of a multicenter, prospective, validation study. Am J Gastroenterol 2006; 101: 2511-2519
12. Kovacevic N, Alempijevic T. Right liver lobe diameter: albumin ratio: a new non-invasive parameter for prediction of oesophageal varices in patients with liver cirrhosis (preliminary report). Gut 2007; 56: 1166-7; authro reply 1167.
13. Rockey DC. Noninvasive assessment of liver fi brosis and portal hypertension with transient elastography. Gastroenterology 2008; 134: 8-14.
14. Cast é ra L, Vergniol J, Foucher J et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fi brosis in chronic hepatitis C. Gastroenterology 2005; 128: 343-350
15. Lucidarme D, Foucher J, Le Bail B et al. Factors of accuracy of transient elastography (fi broscan) for the diagnosis of liver fi brosis in chronic hepatitis C. Hepatology 2009; 49: 1083-1089
16. Cast é ra L, Le Bail B, Roudot-Th oraval F et al. Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores. J Hepatol 2009; 50: 59-68.
17. Marcellin P, Ziol M, Bedossa P et al. Non-invasive assessment of liver fi brosis by stiff ness measurement in patients with chronic hepatitis B. Liver Int 2009; 29: 242-247
18. Dittrich M, Milde S, Dinkel E et al. Sonographic biometry of liver and spleen size in childhood. Pediatr Radiol 1983; 13: 206-211
19. Ziol M, Handra-Luca A, Kettaneh A et al. Noninvasive assessment of liver fi brosis by measurement of stiff ness in patients with chronic hepatitis C. Hepatology 2005; 41: 48-54.
20. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983; 148: 839-843
21. Chan HL, Wong GL, Choi PC et al. Alanine aminotransferase-based algorithms of liver stiff ness measurement by transient elastography (Fibroscan) for liver fi brosis in chronic hepatitis B. J Viral Hepat 2009; 16: 36-44.
22. Coco B, Oliveri F, Maina AM et al. Transient elastography: a new surrogate marker of liver fi brosis infl uenced by major changes of transaminases. J Viral Hepat 2007; 14: 360-369
23. Kim BK, Kim SA, Park YN et al. Noninvasive models to predict liver cirrhosis in patients with chronic hepatitis B. Liver Int 2007; 27: 969-976
24. Wai CT, Greenson JK, Fontana RJ et al. A simple noninvasive index can predict both signifi cant fi brosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003; 38: 518-526
25. Sheth SG, Flamm SL, Gordon FD et al. AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection. Am J Gastroenterol 1998; 93: 44-48
26. Poynard T, Bedossa P. Age and platelet count: a simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus. METAVIR and CLINIVIR Cooperative Study Groups. J Viral Hepat 1997; 4: 199-208.
27. Bosch J, Garcia-Pagá n JC, Berzigotti A et al. Measurement of portal pressure and its role in the management of chronic liver disease. Semin Liver Dis 2006; 26: 348-362
28. Lim JK, Groszmann RJ. Transient elastography for diagnosis of portal hypertension in liver cirrhosis: is there still a role for hepatic venous pressure gradient measurement? Hepatology 2007; 45: 1087-1090
29. Giannini EG. Review article: thrombocytopenia in chronic liver disease and pharmacologic treatment options. Aliment Pharmacol Ther 2006; 23: 1055-1065
30. Poynard T, Trabut JB, Ratziu V et al. Prediction of oesophageal varices with platelet count/spleen diameter ratio or platelets alone. Gut 2004; 53: 913-4; author reply 914.
31. O'Donohue J, Ng C, Catnach S et al. Diagnostic value of Doppler assessment of the hepatic and portal vessels and ultrasound of the spleen in liver disease. Eur J Gastroenterol Hepatol 2004; 16: 147-155
32. Sandrin L, Fourquet B, Hasquenoph JM et al. Transient elastography: a new noninvasive method for assessment of hepatic fi brosis. Ultrasound Med Biol 2003; 29: 1705-1713
33. Liu CH, Lin JW, Tsai FC et al. Noninvasive tests for the prediction of signifi cant hepatic fi brosis in hepatitis C virus carriers with persistently normal alanine aminotransferases. Liver Int 2006; 26: 1087-1094